Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,826 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment patterns for AL amyloidosis after frontline daratumumab, bortezomib, cyclophosphamide, and dexamethasone treatment failures.
Zanwar S, Gertz MA, Muchtar E, Buadi FK, Kourelis T, Gonsalves W, Go RS, Hayman S, Kapoor P, Binder M, Cook J, Dingli D, Leung N, Lin Y, Warsame R, Fonder A, Hobbs M, Hwa YL, Kyle RA, Rajkumar SV, Kumar S, Dispenzieri A. Zanwar S, et al. Among authors: kyle ra. Leukemia. 2024 Apr 9. doi: 10.1038/s41375-024-02243-5. Online ahead of print. Leukemia. 2024. PMID: 38594348 No abstract available.
Adaptation and qualitative evaluation of the BETTER intervention for chronic disease prevention and screening by public health nurses in low income neighbourhoods: views of community residents.
O'Brien MA, Lofters A, Wall B, Elliott R, Makuwaza T, Pietrusiak MA, Grunfeld E, Riordan B, Snider C, Pinto AD, Manca D, Sopcak N, Cornacchi SD, Huizinga J, Sivayoganathan K, Donnelly PD, Selby P, Kyle R, Rabeneck L, Baxter NN, Tinmouth J, Paszat L. O'Brien MA, et al. Among authors: kyle r. BMC Health Serv Res. 2024 Apr 4;24(1):427. doi: 10.1186/s12913-024-10853-z. BMC Health Serv Res. 2024. PMID: 38575938 Free PMC article.
Outcomes of patients with multiple myeloma refractory to standard dose vs low dose lenalidomide.
Goel U, Charalampous C, Kapoor P, Binder M, Buadi FK, Dingli D, Dispenzieri A, Fonder A, Gertz MA, Gonsalves WI, Hayman SR, Hobbs MA, Hwa YL, Kourelis T, Lacy MQ, Leung N, Lin Y, Warsame RM, Kyle RA, Rajkumar SV, Kumar SK. Goel U, et al. Among authors: kyle ra. Blood Cancer J. 2024 Mar 26;14(1):55. doi: 10.1038/s41408-024-01039-1. Blood Cancer J. 2024. PMID: 38531841 Free PMC article.
Predictors and Impact of Timing of Disease Progression Following Primary Therapy in Multiple Myeloma.
Goldman-Mazur S, Visram A, Rajkumar SV, Kapoor P, Dispenzieri A, Lacy MQ, Gertz MA, Buadi FK, Hayman SR, Dingli D, Kourelis T, Gonsalves W, Warsame R, Muchtar E, Leung N, Kyle RA, Kumar SK. Goldman-Mazur S, et al. Among authors: kyle ra. Clin Lymphoma Myeloma Leuk. 2024 Mar;24(3):e104-e111.e1. doi: 10.1016/j.clml.2023.11.008. Epub 2023 Nov 27. Clin Lymphoma Myeloma Leuk. 2024. PMID: 38135634
Muscle and fat composition in patients with newly diagnosed multiple myeloma.
Abdallah NH, Nagayama H, Takahashi N, Gonsalves W, Fonder A, Dispenzieri A, Dingli D, Buadi FK, Lacy MQ, Hobbs M, Gertz MA, Binder M, Kapoor P, Warsame R, Hayman SR, Kourelis T, Hwa YL, Lin Y, Kyle RA, Rajkumar SV, Broski SM, Kumar SK. Abdallah NH, et al. Among authors: kyle ra. Blood Cancer J. 2023 Dec 12;13(1):185. doi: 10.1038/s41408-023-00934-3. Blood Cancer J. 2023. PMID: 38086801 Free PMC article.
1,826 results